Alphavestcapital.com on Twitter has posted this about our MMs and why they are hitting on NWBO:
Day 3: Knight Capital and Virtu. - I figured out why they, Citadel and Susquehanna drove down Northwest Biotherapeutics. To protect their interests in Merck, Bayer, Johnson & Johnson and ORIC Pharmaceuticals. (There may be more, this is just what I found) 📚 Due Diligence Hello Beautiful Apeys!
I initially set out to write an educational series about the fines and shady tactics of some of Wall Street’s biggest players. Today was supposed to be day 3, highlighting Knight Capital Group, but as I kept digging into Knight Capital and Virtu Financial, I uncovered a deeper story involving Northwest Biotherapeutics (NWBO). This is no longer just about fines—it’s about market manipulation meant to stop a life-saving cancer treatment. What I found connects these hedge funds to Merck, Johnson & Johnson, Bayer, and their efforts to crush innovation in cancer treatment.
Part 1 and 2 if you missed them.
Let’s expose this corruption together! ♥
Part 1: Knight Capital and Virtu In 2012, Knight Capital suffered a $440 million loss in 45 minutes due to a "software glitch" that sent erroneous trades into the market, tanking the stock prices of nearly 150 companies. This event marked one of the most infamous trading errors in history? (Violation Tracker). In 2017, Virtu Financial acquired Knight Capital as part of its expansion into high-frequency trading (HFT). Both companies are key players in HFT, a trading strategy that uses automation to execute trades at incredibly high speeds. While Knight’s trading error was a result of faulty code, Virtu has continued to dominate the market-making world, though it has faced regulatory scrutiny for spoofing and market manipulation (Wikipedia)?.
This is just my theory, but I suspect that the $440 million loss was offset by a large profit by other market makers and hedge funds. I think they did that on purpose tbh. Think about it... What is the big boi playbook? Their bread and butter? Naked shorting. Cellar boxing. Driving companies down and profiting.
So you mean to tell me that in a world where collusion and corruption are the norm, a random software glitch was the real cause, driving 150 companies down 10%? I HIGHLY doubt it.
I think they coordinated that, and if we look into it (I will later, not today, this is about NWBO), we'll find exactly what we think we'll find. Knight lost money, but their big boi bros probably made a lot more. And that "emergency funding" came from the profits of this "glitch." Just my opinion.
Part 2: NWBO’s Breakthrough Treatment and Big Pharma’s Problem NWBO’s DCVax-L is a breakthrough cancer treatment designed to target glioblastoma multiforme (GBM), one of the deadliest brain cancers. Unlike traditional treatments like chemotherapy, which causes serious side effects, DCVax-L trains the immune system to target and destroy tumors. This is where Merck comes in.
Merck produces Temodar, the standard chemotherapy drug for GBM. If DCVax-L succeeds, it could replace Temodar, cutting deep into Merck’s multi-billion dollar revenue stream from this drug?. Bayer is heavily invested in Stivarga, a drug used to treat several cancers, including brain tumors. If immunotherapies like DCVax-L gain traction, older drugs like Stivarga could become obsolete, impacting Bayer's profits.
While Johnson & Johnson doesn’t produce glioblastoma treatments, they are heavily invested in immuno-oncology. If personalized cancer treatments like DCVax-L start dominating the market, it could disrupt J&J’s pipeline of next-gen therapies, forcing them to rethink their strategies.
Translation for Apes: NWBO’s success would threaten Big Pharma’s outdated treatments, actually saving lives but costing companies like Merck and Bayer billions. And we can't have that, can we.. /s
Part 3: Merck’s Stake and the Hedge Fund Connection What ties all of this together is the ownership stakes these hedge funds hold in Big Pharma.
Citadel holds $1 billion in Merck stock and also $1 billion in Johnson & Johnson stock, meaning they have a vested interest in protecting Merck’s revenue from Temodar, which could be wiped out by DCVax-L? (Fintel)(StockZoa).
Susquehanna also owns a significant stake in Merck, valued at around $764 million, reinforcing the idea that hedge funds are working to protect Merck’s profits by manipulating NWBO’s stock (StockZoa). Virtu holds investments in ORIC Pharmaceuticals, a firm collaborating with Bayer on cancer treatments. If DCVax-L takes off, ORIC and other companies tied to traditional cancer drugs could face massive losses? (Formthirteen).
Translation for Apes: Citadel, Virtu, and Susquehanna have major financial interests in keeping Merck’s drugs on top, and they’re pulling every trick in the book to protect those profits. It's worth mentioning that Vanguard has $34 BILLION and Blackrock has $29 BILLION in Johnson & Johnson stock.
Now the dots are starting to connect. I'll do a longer DD on both of them tomorrow for Day 4.📷
Part 4: The Naked Shorting and Spoofing Tactics The most damning part of this scheme is the naked shorting and spoofing used to artificially suppress NWBO’s stock. These hedge funds sold shares they didn’t even own, driving down the price of NWBO while simultaneously placing fake sell orders to create the illusion of heavy selling. This manipulation peaked when positive trial results for DCVax-L were announced, and instead of the stock rising, it plummeted by 78%—all to protect their investments in Merck and Bayer? (Link to the NWBO court case: PacerMonitor Federal Court Case Tools).
Translation for Apes: These hedge funds are rigging the system by naked shorting and spoofing NWBO’s stock to protect their investments in outdated cancer treatments. It's the big boi club. We're tearing at the seams here.
TL;DR Knight Capital’s disaster lives on through Virtu Financial, which, along with Citadel and Susquehanna, is manipulating the market to suppress NWBO, a company developing a revolutionary cancer treatment. Why? Because NWBO’s success threatens the outdated cancer treatments produced by Merck, Bayer, ORIC Pharmaceuticals, and Johnson & Johnson. And probably others. These hedge funds are using illegal tactics like naked shorting and spoofing to protect their billions in profits, while delaying life-saving innovations like DCVax-L. Stay strong, Apes—because the truth is uglier than we thought. 🦍💪
AI
